 |
A track record in developing commercially successful
hybridoma lines. |
|
Specialist knowledge of hollow fibre bioreactor technology
- now accepted by regulatory agencies for the manufacture
of therapeutic proteins. |
|
Expertise in working with serum - free systems. |
|
Expertise in characterisation of products and documentation
of data suitable for regulatory submissions. |
|
Cost-effective, multi-purpose, flexible manufacturing
facilities providing access to hollow fibre, fermenter
, roller and spinner culture technologies, enabling us
to tailor our services to your individual requirements. |
|
Access to other essential services (eg. biosafety testing)
to facilitate and expedite product development through
to market. |
|
Completion of contracts within well defined budgets
and timelines. |
|
A customer service record second to none from your initial
enquiry to delivery of product. |
|
The nature of our services requires us to work with
our clients in a confidential, creative, synergystic partnership
to ensure that their corporate goals are achieved. This
commitment to client and project is key to our success.
We will work with you through an evaluation and optimisation
programme, manufacturing your product to pilot scale and
validating the production processes to facilitate scale-up
for clinical trials. From the moment of your first enquiry
you are assured of a high level of service from our customer
focused team. |
